Schroeder Comments on Expected Pro-Employer Tilt of NLRB
24 April 2018
Business Insurance
Partner Don Schroeder was quoted in an article in Business Insurance, “Pro-employer bent seen with NLRB’s new GOP majority,” about the future direction of the National Labor Relations Board under a new Republican majority.
Schroeder said “there was a real effort” by the Democrat-controlled board during the Obama administration to weigh in on confidentiality agreements, confidentiality policies, social media policies and electronic communication policies in an effort to expand the NLRB’s scope and jurisdiction. But he also said he didn’t expect any instant or dramatic changes in its Obama-era rulings.
“I don’t think there’s going to be an edict from the general counsel’s office that rescinds” any of the memoranda issued during the Obama administration, but at the same time, “you’ll see less evidence of unfair labor practice charges” going before the agency’s administrative law judges in the future, he said.
Schroeder said “there was a real effort” by the Democrat-controlled board during the Obama administration to weigh in on confidentiality agreements, confidentiality policies, social media policies and electronic communication policies in an effort to expand the NLRB’s scope and jurisdiction. But he also said he didn’t expect any instant or dramatic changes in its Obama-era rulings.
“I don’t think there’s going to be an edict from the general counsel’s office that rescinds” any of the memoranda issued during the Obama administration, but at the same time, “you’ll see less evidence of unfair labor practice charges” going before the agency’s administrative law judges in the future, he said.
People
Related News
13 December 2024
In the News
Brian Tomkins Featured Across Legal Press for Arrival to Foley
Foley & Lardner LLP partner Brian Tomkins is featured across legal press for his recent arrival to the firm.
11 December 2024
In the News
Nathan Beaver Discusses GLP-1 Compounding, FDA Deliberations
Foley & Lardner LLP partner Nathan Beaver discussed the ongoing deliberations at the U.S. Food and Drug Administration over a popular class of drugs in the PharmaVoice article, "GLP-1 compounding is still in limbo. Will the FDA leave it for the next administration?"
11 December 2024
In the News
Brian Wheeler Quoted on Dealmaking in GP-led Secondaries Market
Foley & Lardner LLP partner Brian Wheeler commented in the Pitchbook article, "GP-led secondaries to end 2024 with new record," assessing the prospects for dealmaking in the space heading into 2025.